Sisram Medical Ltd (HKG:1696)
3.000
-0.020 (-0.66%)
Apr 29, 2026, 4:08 PM HKT
Sisram Medical Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 1,405 | 1,972 | 1,770 | 2,463 | 4,168 | 4,424 | Upgrade
|
| Market Cap Growth | -42.42% | 11.38% | -28.14% | -40.90% | -5.78% | 202.27% | Upgrade
|
| Enterprise Value | 1,425 | 2,021 | 1,719 | 2,428 | 3,292 | 3,687 | Upgrade
|
| Last Close Price | 3.00 | 4.21 | 3.70 | 4.87 | 8.06 | 8.46 | Upgrade
|
| PE Ratio | 9.49 | 13.32 | 9.07 | 10.01 | 13.31 | 18.16 | Upgrade
|
| Forward PE | 6.17 | 11.88 | 11.88 | 11.88 | 11.88 | 11.88 | Upgrade
|
| PS Ratio | 0.49 | 0.69 | 0.65 | 0.88 | 1.51 | 1.93 | Upgrade
|
| PB Ratio | 0.36 | 0.50 | 0.47 | 0.67 | 1.24 | 1.41 | Upgrade
|
| P/TBV Ratio | 0.83 | 1.17 | 1.17 | 1.67 | 1.95 | 2.37 | Upgrade
|
| P/FCF Ratio | 26.48 | 37.17 | 7.51 | 8.92 | 30.93 | 19.29 | Upgrade
|
| P/OCF Ratio | 19.21 | 26.96 | 6.89 | 7.18 | 24.26 | 17.52 | Upgrade
|
| PEG Ratio | - | 0.57 | 0.57 | 0.57 | 0.57 | 0.57 | Upgrade
|
| EV/Sales Ratio | 0.50 | 0.71 | 0.63 | 0.87 | 1.19 | 1.61 | Upgrade
|
| EV/EBITDA Ratio | 4.11 | 6.79 | 5.69 | 6.54 | 7.82 | 9.17 | Upgrade
|
| EV/EBIT Ratio | 6.72 | 9.61 | 8.00 | 8.17 | 9.30 | 11.06 | Upgrade
|
| EV/FCF Ratio | 26.86 | 38.10 | 7.30 | 8.79 | 24.43 | 16.08 | Upgrade
|
| Debt / Equity Ratio | 0.10 | 0.10 | 0.09 | 0.10 | 0.10 | 0.10 | Upgrade
|
| Debt / EBITDA Ratio | 1.17 | 1.17 | 0.96 | 0.85 | 0.72 | 0.76 | Upgrade
|
| Debt / FCF Ratio | 7.59 | 7.59 | 1.42 | 1.26 | 2.39 | 1.42 | Upgrade
|
| Net Debt / Equity Ratio | -0.04 | -0.04 | -0.06 | -0.06 | -0.12 | -0.29 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.56 | -0.56 | -0.80 | -0.56 | -0.93 | -2.25 | Upgrade
|
| Net Debt / FCF Ratio | -3.12 | -3.12 | -1.02 | -0.75 | -2.90 | -3.96 | Upgrade
|
| Asset Turnover | 0.57 | 0.57 | 0.56 | 0.62 | 0.65 | 0.61 | Upgrade
|
| Inventory Turnover | 1.72 | 1.72 | 1.64 | 1.80 | 2.19 | 2.51 | Upgrade
|
| Quick Ratio | 1.62 | 1.62 | 1.66 | 1.88 | 2.15 | 2.73 | Upgrade
|
| Current Ratio | 2.60 | 2.60 | 2.61 | 2.92 | 3.13 | 3.56 | Upgrade
|
| Return on Equity (ROE) | 5.06% | 5.06% | 6.03% | 7.30% | 9.59% | 8.84% | Upgrade
|
| Return on Assets (ROA) | 2.63% | 2.63% | 2.79% | 4.07% | 5.23% | 5.56% | Upgrade
|
| Return on Invested Capital (ROIC) | 4.91% | 5.06% | 5.46% | 8.17% | 12.29% | 12.43% | Upgrade
|
| Return on Capital Employed (ROCE) | 4.90% | 4.90% | 5.20% | 7.20% | 9.60% | 9.60% | Upgrade
|
| Earnings Yield | 10.53% | 7.51% | 11.02% | 9.99% | 7.51% | 5.51% | Upgrade
|
| FCF Yield | 3.78% | 2.69% | 13.31% | 11.21% | 3.23% | 5.18% | Upgrade
|
| Dividend Yield | 3.15% | 2.26% | 3.41% | 3.24% | 2.15% | 1.86% | Upgrade
|
| Payout Ratio | 39.64% | 39.64% | 37.61% | 33.37% | 23.21% | 13.41% | Upgrade
|
| Buyback Yield / Dilution | - | - | -0.21% | -0.34% | -3.07% | -2.42% | Upgrade
|
| Total Shareholder Return | 3.15% | 2.26% | 3.20% | 2.91% | -0.93% | -0.57% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.